BioVie Inc. (BIVI)

[ejobkar]

Very nice!

Also listed (About BioVie), "As of April 2019, all six of the planned patients had been treated with BIV201 therapy and the results are being analyzed for presentation to the Food & Drug Administration (“FDA”) in the first half of 2019."

Open question - if the results (at this point) were not forward looking, why seek capital from investors and spend the time making an official announcement for it? This tells me they are ramping up from a successful Phase 2a completion and thinking ahead to possible Phase 3 FDA trials which will require lots of capital/funding.